rs376808920
Positions:
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 0P and 4B. BS2
The NM_005921.2(MAP3K1):c.934A>T(p.Met312Leu) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000104 in 1,614,038 control chromosomes in the GnomAD database, including 6 homozygotes. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Genomes: 𝑓 0.00020 ( 4 hom., cov: 32)
Exomes 𝑓: 0.000094 ( 2 hom. )
Consequence
MAP3K1
NM_005921.2 missense
NM_005921.2 missense
Scores
2
5
12
Clinical Significance
Conservation
PhyloP100: 8.03
Genes affected
MAP3K1 (HGNC:6848): (mitogen-activated protein kinase kinase kinase 1) The protein encoded by this gene is a serine/threonine kinase and is part of some signal transduction cascades, including the ERK and JNK kinase pathways as well as the NF-kappa-B pathway. The encoded protein is activated by autophosphorylation and requires magnesium as a cofactor in phosphorylating other proteins. This protein has E3 ligase activity conferred by a plant homeodomain (PHD) in its N-terminus and phospho-kinase activity conferred by a kinase domain in its C-terminus. [provided by RefSeq, Mar 2012]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -4 ACMG points.
BS2
High AC in GnomAd4 at 30 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MAP3K1 | NM_005921.2 | c.934A>T | p.Met312Leu | missense_variant | 4/20 | ENST00000399503.4 | NP_005912.1 | |
MAP3K1 | XM_047417218.1 | c.934A>T | p.Met312Leu | missense_variant | 4/18 | XP_047273174.1 | ||
MAP3K1 | XM_047417219.1 | c.523A>T | p.Met175Leu | missense_variant | 5/21 | XP_047273175.1 | ||
MAP3K1 | XM_047417220.1 | c.523A>T | p.Met175Leu | missense_variant | 5/21 | XP_047273176.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MAP3K1 | ENST00000399503.4 | c.934A>T | p.Met312Leu | missense_variant | 4/20 | 1 | NM_005921.2 | ENSP00000382423.3 |
Frequencies
GnomAD3 genomes AF: 0.000197 AC: 30AN: 152166Hom.: 4 Cov.: 32
GnomAD3 genomes
AF:
AC:
30
AN:
152166
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000561 AC: 14AN: 249368Hom.: 0 AF XY: 0.0000296 AC XY: 4AN XY: 135286
GnomAD3 exomes
AF:
AC:
14
AN:
249368
Hom.:
AF XY:
AC XY:
4
AN XY:
135286
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000944 AC: 138AN: 1461872Hom.: 2 Cov.: 32 AF XY: 0.0000825 AC XY: 60AN XY: 727244
GnomAD4 exome
AF:
AC:
138
AN:
1461872
Hom.:
Cov.:
32
AF XY:
AC XY:
60
AN XY:
727244
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000197 AC: 30AN: 152166Hom.: 4 Cov.: 32 AF XY: 0.0000673 AC XY: 5AN XY: 74330
GnomAD4 genome
AF:
AC:
30
AN:
152166
Hom.:
Cov.:
32
AF XY:
AC XY:
5
AN XY:
74330
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ExAC
AF:
AC:
9
Asia WGS
AF:
AC:
7
AN:
3478
ClinVar
Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:3Benign:1
Revision: criteria provided, conflicting classifications
LINK: link
Submissions by phenotype
46,XY sex reversal 6 Uncertain:2Benign:1
Uncertain significance, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Jan 03, 2024 | - - |
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jul 29, 2023 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | Victorian Clinical Genetics Services, Murdoch Childrens Research Institute | Mar 31, 2022 | Based on the classification scheme VCGS_Germline_v1.3.4, this variant is classified as VUS-3B. Following criteria are met: 0101 - Gain of function is a known mechanism of disease in this gene and is associated with 46,XY sex reversal 6 (MIM#613762). Functional studies of missense variants observed in affected individuals have shown they increase phosphorylation of downstream products causing increased activation of the MAPK pathway (PMIDs: 24135036, 21129722, 30608580). (I) 0107 - This gene is associated with autosomal dominant disease. The condition associated with this gene is inherited in a sex limited manner; only individuals with a 46,XY karyotype are affected (PMID: 20301714). (I) 0115 - Variants in this gene are known to have variable expressivity. Intrafamilial and interfamilial variability have been reported, with individuals harbouring the same variants observed to have variable phenotypes, ranging from hypospadias to complete gonadal dysgenesis (PMIDs: 27899157, 12476449, 21129722). (I) 0200 - Variant is predicted to result in a missense amino acid change from methionine to leucine. (I) 0251 - This variant is heterozygous. (I) 0309 - An alternative amino acid change at the same position has been observed in gnomAD (v3) (2 heterozygotes, 0 homozygotes). (I) 0310 - Variant is present in gnomAD (v3) >=0.001 and <0.01 for a dominant condition (22 heterozygotes, 4 homozygotes). However, the four homozygotes and 17 heterozygotes had an XX karyotype and would therefore be expected to be unaffected carriers of 46,XY sex reversal. (I) 0502 - Missense variant with conflicting in silico predictions and high conservation. (I) 0604 - Variant is not located in an established domain, motif, hotspot or informative constraint region. (I) 0705 - No comparable missense variants have previous evidence for pathogenicity. (I) 0803 - This variant has limited previous evidence of pathogenicity in unrelated individuals. This variant has been classified as likely pathogenic in four individuals in the literature with variable phenotypes including hypospadias, disorders of sex development, and complete gonadal dysgenesis (PMID: 27899157). However, two of these individuals also had a variant in another gene associated with DSD. This variant has also been classified as likely pathogenic, likely benign and as a VUS by clinical laboratories in ClinVar. (SP) 0905 - No published segregation evidence has been identified for this variant. (I) 1007 - No published functional evidence has been identified for this variant. (I) 1208 - Inheritance information for this variant is not currently available in this individual. (I) Legend: (SP) - Supporting pathogenic, (I) - Information, (SB) - Supporting benign - |
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Genetic Services Laboratory, University of Chicago | Mar 31, 2020 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Uncertain
CADD
Benign
DANN
Benign
DEOGEN2
Benign
T
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Pathogenic
D
LIST_S2
Uncertain
D
M_CAP
Benign
T
MetaRNN
Uncertain
T
MetaSVM
Benign
T
MutationAssessor
Benign
L
PrimateAI
Pathogenic
D
PROVEAN
Benign
N
REVEL
Benign
Sift
Benign
T
Sift4G
Benign
T
Polyphen
P
Vest4
MutPred
Gain of ubiquitination at K310 (P = 0.0514);
MVP
MPC
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at